Drugs / Coconut oil
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT07175090 | Jun 2024 → Feb 2025 | periodontitis | University of Pristina | Completed | No outcome recorded |
| Phase 0 | NCT03185169 | Nov 2016 → Jul 2018 | female breast carcinoma, urinary tract infection, urogenital tract malformation, vaginal disorder | Alta Bates Summit Medical Center | Terminated | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00336908 | Nov 2005 → Nov 2007 | — | University of Alberta | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07100145 | Nov 2025 → Aug 2026 | lichen planus, oral | Ain Shams University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT06384638 Comparator | Feb 2022 → Jan 2024 | periodontitis | Misr University for Science and Technology | Completed | No outcome recorded |
| Phase 2 | NCT02543203 Comparator | Jul 2015 → Mar 2018 | anxiety, autism spectrum disorder | Jill Hollway | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | coconut oil | “Medium Chain Triglyceride i.e. coconut oil” NCT00336908 ↗ |
| Route | Topical | “coconut oil applied at the vaginal introitus and vulva” NCT03185169 ↗ |